Perspectives on the TransCelerate Shared Investigator Platform

TransCelerate BioPharma, a nonprofit industry collaboration, was formed in 2012 by a group of leading pharmaceutical organizations. One of TransCelerate’s areas of focus is improving the site investigator experience. To that end, the group has created the Shared Investigator Platform (SIP), designed to serve as a single, cloud-based, digital interface for all clinical investigators conducting research for any of the TransCelerate member companies.  

This guide:

• Discusses the benefits and challenges associated with adopting the SIP
• Offers SIP-related guidance for companies that are considering joining TransCelerate
• Provides SIP-related recommendations for companies that are already members